Evidence map›Paper›PMID 20662786›Full record

SynthesisAlimentary pharmacology & therapeutics2010

Meta-analysis: do irritable bowel syndrome symptoms vary between men and women?

M A Adeyemo, B M R Spiegel, L Chang

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Alimentary pharmacology & therapeutics, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed, 4 pooled it
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 4 syntheses or guidelines pooled it, 180 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Efficacy and dose response ofWorld journal of gastroenterology · 2023
    Trial
  6. Trial
  7. Article
  8. Article
  9. Menopause and gastrointestinal health and disease.Nature reviews. Gastroenterology & hepatology · 2025
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Factors associated with irritable bowel syndrome andThe Journal of international medical research · 2024
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

M A AdeyemoCenter for Neurobiology of Stress, Los Angeles, CA 90095, USA.
B M R Spiegel
L Chang
VA Greater Los Angeles Healthcare System · US

Funding

ZDV &3TC NEVIRAPINE COMBINATION THERAPY IN HIV 1 INFECTED INFANTS &M01RR000865 · NCRR · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WASHINGTON, ARNOLD E. · 1985 to 2011
$43.4M
Women's Health and Functional Visceral Disorders CenterP50DK064539 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MAYER, EMERAN A · 2002 to 2017
$17.5M
Mind/Brain/Body Interactions in Stress-Related DisordersR24AT002681 · NCCIH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MAYER, EMERAN A · 2004 to 2008
$4.6M
NCCIH NIH HHS R24 AT002681NCRR NIH HHS M01 RR000865NIDDK NIH HHS P50 DK064539NIDDK NIH HHS P50 DK64539
6 · The paper itself

Abstract

backgroundStudies suggest that sex and gender-related differences exist in irritable bowel syndrome (IBS), but data is often conflicting.

aimTo evaluate gender differences and the effect of menstrual cycle and menopausal status on IBS symptoms.

methodsWe performed a systematic review of MEDLINE to search for studies comparing IBS symptoms between gender, menstrual cycle phases and menopausal states in IBS and/or healthy individuals. We performed meta-analyses to compare the relative risk (RR) of individual IBS symptoms between men and women.

resultsTwenty-two studies measured gender differences in IBS symptoms. Women were more likely to report abdominal pain (RR = 1.12, 95% CI: 1.02, 1.22) and constipation-related symptoms (RR = 1.12, 95% CI: 1.02, 1.23) than men (all P < 0.05). However, men with IBS were more likely to report diarrhoea-related symptoms than women with IBS (RR = 0.84, 95% CI: 0.75, 0.94, P < 0.05). A systematic review of 13 studies demonstrated that both IBS and healthy women reported increased IBS symptoms during menses vs. other phases. There were insufficient data to determine the effect of menopause and hormone supplementation on IBS symptoms.

conclusionsIn the general and IBS populations, gender differences in IBS symptoms exist, although these differences are modest. Studies suggest that female sex hormones influence the severity of IBS symptoms, but more studies are needed.

Indexed as

Abdominal PainAdultAgedAged, 80 and overConstipationDiarrheaFemaleHumansIrritable Bowel SyndromeMaleMenstrual CycleMiddle AgedPerceptionSeverity of Illness IndexSex FactorsStatistics as Topic

Identifiers

PMID20662786
PMCPMC2932820
OpenAlexW1956460762

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.